• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings

    4/17/24 10:07:53 AM ET
    $ABT
    $EDBL
    $INVO
    $IZM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $ABT alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday.

    Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ rose 0.24% to 15,903.38. The S&P 500 also rose, gaining, 0.40% to 5,071.74.

    Check This Out: Alphabet, Toll Brothers And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Materials shares rose by 1% on Wednesday.

    In trading on Wednesday, real estate shares fell by 0.3%.

     

    Top Headline

     

    Abbott Laboratories (NYSE:ABT) reported better-than-expected earnings for its first quarter.

    The company posted first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion. Abbott’s adjusted diluted earnings per share was 98 cents, beating the analyst estimates of 95 cents.

     

    Equities Trading UP

     

    Abbott Laboratories (NASDAQ:INVO) shares shot up 203% to $2.35 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024.

    Shares of Edible Garden AG Incorporated (NASDAQ:EDBL) got a boost, surging 118% to $9.94 after the company reported preliminary first quarter fy24 results.

    VIA optronics AG (NASDAQ:VIAO) shares were also up, gaining 55% to $0.4028 after dipping over 15% on Tuesday.

     

    Equities Trading DOWN

     

    ICZOOM Group Inc. (NASDAQ:IZM) shares dropped 91% to $4.61.

    Shares of Sunshine Biopharma, Inc. (NASDAQ:SBFM) were down 46% to $3.6932.

    Trio Petroleum Corp. (NASDAQ:TPET) was down, falling 36% to $0.3091 after dipping over 22% on Tuesday.

    Also Check This Out: How To Earn $500 A Month From Intel Stock Ahead Of Q1 Earnings

     

    Commodities

     

    In commodity news, oil traded down 0.8% to $84.69 while gold traded down 0.2% at $2,402.10.

    Silver traded up 0.6% to $28.55 on Wednesday, while copper rose 0.3% to $4.3150.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 gained 0.7%, London’s FTSE 100 rose 0.6% while Spain’s IBEX 35 Index gained 1.4% The German DAX gained 0.7% French CAC 40 climbed 1.4% while Italy’s FTSE MIB Index gained 1.1%.

    The consumer price inflation rate in the Eurozone came in at 2.4% year-over-year in March. The UK’s inflation rate eased to 3.2% year-over-year in March versus 3.4% in the prior month, while producer prices increased 0.6% year-over-year in March.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Wednesday, with Japan’s Nikkei 225 falling 1.32%, Hong Kong’s Hang Seng Index gaining 0.02% and China’s Shanghai Composite gaining 2.14%.

    Japan recorded a trade surplus of JPY 366,467 billion in March versus a deficit of JPY 750,854 billion in the year-ago period, while the Reuters Tankan sentiment index for manufacturers declined to +9 in April versus March’s reading of +10.

     

    Economics

     

    U.S. mortgage applications climbed by 3.3% in the latest week.


    Now Read This: Top 5 Tech And Telecom Stocks That May Rocket Higher This Month

     

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $EDBL
    $INVO
    $IZM

    CompanyDatePrice TargetRatingAnalyst
    Abbott Laboratories
    $ABT
    4/22/2026$92.00Outperform → Neutral
    Daiwa Securities
    Abbott Laboratories
    $ABT
    10/10/2025$145.00Buy
    The Benchmark Company
    Abbott Laboratories
    $ABT
    7/18/2025$145.00Hold → Buy
    Jefferies
    Abbott Laboratories
    $ABT
    6/16/2025$143.00Market Perform
    Leerink Partners
    Abbott Laboratories
    $ABT
    10/8/2024$130.00Outperform
    Oppenheimer
    Abbott Laboratories
    $ABT
    9/19/2024$131.00Overweight
    Piper Sandler
    Abbott Laboratories
    $ABT
    7/30/2024Buy → Hold
    Edward Jones
    Abbott Laboratories
    $ABT
    5/30/2024$121.00Buy
    Goldman
    More analyst ratings

    $ABT
    $EDBL
    $INVO
    $IZM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $EDBL
    $INVO
    $IZM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edible Garden Wins Major New Fresh-Cut Herb Program at Target Stores

    BELVIDERE, NJ, April 21, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products today announced it has been awarded new distribution with Target, expanding its existing relationship with the retailer to supply a substantial portion of its fresh cut herbs. The award marks a meaningful expansion of Edible Garden's retail presence and reflects growing demand for its organic and sustainably grown products. This increased business with Target is expected to accelerate revenue growth, increase brand visibility, and strengthen

    4/21/26 9:19:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

    Data show how a multi-biomarker class approach improves early-stage cancer detectionAACR will also recognize landmark DETECT-A study publication reporting long-term outcomes supporting the clinical impact of MCEDABBOTT PARK, Ill., April 17, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) will present new data at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating continued advancements in its multi-biomarker, multi-cancer early detection (MCED) program supporting the commercially available Cancerguard® test. Additionally, the AACR Cancer Prevention Research Award for Outstanding Journal Article will recognize a publication on MCED multiyear outcomes from the DETECT-A

    4/17/26 3:30:00 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Edible Garden Secures $2.66 Million from Iowa Economic Development Authority to Accelerate Ready-to-Drink Tetra Pak Facility

    BELVIDERE, NJ, April 17, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced the strategic redevelopment of the former National Shrimp facility in Webster City, Iowa into a new, large-scale, technology-driven ready-to-drink (RTD) beverage production hub. Supported by a recently approved $2.66 million incentive package from the Iowa Economic Development Authority, this initiative reflects the Company's continued execution of its Farm to Formula® strategy and its move into higher-value, shelf-stable nut

    4/17/26 9:08:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $ABT
    $EDBL
    $INVO
    $IZM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Abbott Labs downgraded by Daiwa Securities with a new price target

    Daiwa Securities downgraded Abbott Labs from Outperform to Neutral and set a new price target of $92.00

    4/22/26 7:52:11 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Benchmark Company initiated coverage on Abbott Labs with a new price target

    The Benchmark Company initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $145.00

    10/10/25 8:35:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Labs upgraded by Jefferies with a new price target

    Jefferies upgraded Abbott Labs from Hold to Buy and set a new price target of $145.00

    7/18/25 7:54:43 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $EDBL
    $INVO
    $IZM
    SEC Filings

    View All

    Edible Garden AG Incorporated filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Edible Garden AG Inc (0001809750) (Filer)

    4/24/26 4:30:25 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form S-8 filed by Abbott Laboratories

    S-8 - ABBOTT LABORATORIES (0000001800) (Filer)

    4/24/26 4:06:32 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Trio Petroleum Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Trio Petroleum Corp (0001898766) (Filer)

    4/22/26 4:15:17 PM ET
    $TPET
    Oil & Gas Production
    Energy

    $ABT
    $EDBL
    $INVO
    $IZM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Kras James E. bought $2,050 worth of shares (3,700 units at $0.55), increasing direct ownership by 102% to 7,317 units (SEC Form 4)

    4 - Edible Garden AG Inc (0001809750) (Issuer)

    1/5/26 8:51:35 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $ABT
    $EDBL
    $INVO
    $IZM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Pernice Thomas J

    4 - Trio Petroleum Corp (0001898766) (Issuer)

    4/15/26 4:00:26 PM ET
    $TPET
    Oil & Gas Production
    Energy

    SEC Form 4 filed by Natan David

    4 - Sunshine Biopharma Inc. (0001402328) (Issuer)

    4/14/26 4:26:09 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Ross Robin A.

    4 - Trio Petroleum Corp (0001898766) (Issuer)

    4/9/26 5:00:21 PM ET
    $TPET
    Oil & Gas Production
    Energy

    $ABT
    $EDBL
    $INVO
    $IZM
    Financials

    Live finance-specific insights

    View All

    Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

    First-quarter GAAP diluted EPS of $0.61; adjusted diluted EPS of $1.15 reflects growth of 6 percentCompleted acquisition of Exact Sciences, establishing Abbott as a leader in the fast-growing oncology diagnostics marketAbbott projects full-year 2026 comparable sales growth of 6.5% to 7.5%1Abbott projects full-year 2026 adjusted diluted EPS of $5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact SciencesABBOTT PARK, Ill., April 16, 2026 /PRNewswire/ -- Abbott today (NYSE:ABT) announced financial results for the first quarter ended March 31, 2026. First-quarter sales increased 7.8 percent on a reported basis and 3.7 percent on a comparable basis.First-quarter GA

    4/16/26 7:30:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Edible Garden Reports 2025 Results — Accelerates Planned Expansion into Higher-Margin Ready-to-Drink (RTD) and Shelf-Stable CPG Platform

    Targets Large, Underserved RTD Market Opportunity with Scalable Midwest Platform and Tetra Pak Integration  Leverages Established Infrastructure, National Retail Distribution and Growing Brand Portfolio to Drive Expected Higher-Margin, Functional Nutrition Growth Conference Call to Be Held Today at 4:30 pm ET. BELVIDERE, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today reported financial results for the three months and year ended December 31, 2025. The Company continued to build on its

    3/31/26 4:15:00 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Abbott hosts conference call for first-quarter earnings

    ABBOTT PARK, Ill., March 26, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its first-quarter 2026 financial results on Thursday, April 16, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical

    3/26/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $EDBL
    $INVO
    $IZM
    Leadership Updates

    Live Leadership Updates

    View All

    Edible Garden Appoints Board Member Matthew McConnell as Executive Vice President, Strategic Partnerships

    BELVIDERE, NJ, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that Matthew McConnell, a member of the Company's Board of Directors, has joined Edible Garden's senior leadership team full time as Executive Vice President Strategic Partnerships, effective immediately. In this role, Mr. McConnell will be responsible for advancing the Company's strategic initiatives, strengthening relationships with investors and partners, and supporting long-term growth objectives across key channels.

    1/9/26 7:30:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Edible Garden Appoints Capital Markets Veteran Michael Naidrich to Board of Directors

    BELVIDERE, NJ, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW)), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced the appointment of Michael Naidrich to its Board of Directors, effective immediately. Mr. Naidrich has been appointed to the Audit Committee, Compensation Committee and Nominating and Governance Committee and will serve as Chair of the Audit Committee. Mr. Naidrich brings more than three decades of experience in capital markets, financial services leadership, and public-company governance. Mr. Naidrich currently serves

    12/30/25 8:00:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    ICZOOM Group Inc. Appoints Hantao Cui as Chief Strategy Officer and a Director

    Hong Kong, Nov. 12, 2025 (GLOBE NEWSWIRE) -- ICZOOM Group Inc. (NASDAQ:IZM) (the "Company"), a B2B electronic component products e-commerce platform, today announced the appointment of Ms. Hantao Cui as Chief Strategy Officer and a Director of the Company, effective November 11, 2025. Ms. Duanrong Liu will step down from her position as the Chief Operating Officer of the Company, effective November 11, 2025. Hantao Cui has served as Chief Executive Officer of Matrix Science & Technology (Shanghai) Limited since January 2011, where she leads a total solution provider specializing in custom-designed transportation packaging for industrial products. Ms. Cui also serves as a director at Strea

    11/12/25 8:00:00 AM ET
    $IZM
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ABT
    $EDBL
    $INVO
    $IZM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Edible Garden AG Incorporated

    SC 13G/A - Edible Garden AG Inc (0001809750) (Subject)

    11/14/24 7:24:20 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form SC 13G filed by Trio Petroleum Corp.

    SC 13G - Trio Petroleum Corp. (0001898766) (Subject)

    11/14/24 5:34:32 PM ET
    $TPET
    Oil & Gas Production
    Energy

    Amendment: SEC Form SC 13G/A filed by Sunshine Biopharma Inc.

    SC 13G/A - Sunshine Biopharma Inc. (0001402328) (Subject)

    11/14/24 4:28:14 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care